Literature DB >> 20819015

Myelin lesions associated with lysosomal and peroxisomal disorders.

Phyllis L Faust1, Edward M Kaye, James M Powers.   

Abstract

Abnormalities of myelin are common in lysosomal and peroxisomal disorders. Most display a primary loss of myelin in which the myelin sheath and/or oligodendrocytes are selectively targeted by diverse pathogenetic processes. The most severe and, hence, clinically relevant are heritable diseases predominantly of infants and children, the leukodystrophies: metachromatic, globoid cell (Krabbe disease) and adreno-leukodystrophy. Our still limited understanding of these diseases has derived from multiple sources: originally, neurological-neuropathologic-neurochemical correlative studies of the natural disease in humans or other mammals, which has been enhanced by more sophisticated and contemporary techniques of cell and molecular biology. Transgenic mouse models seem to be the most promising methodology, allowing the examination of the cellular role of lysosomes and peroxisomes for formation and maintenance of both myelin and axons, and providing initial platforms to evaluate therapies. Treatment options are woefully inadequate and in their nascent stages, but still inspire some hope for the future.

Entities:  

Mesh:

Year:  2010        PMID: 20819015     DOI: 10.1586/ern.10.127

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  13 in total

1.  A combined approach of quantitative interaction proteomics and live-cell imaging reveals a regulatory role for endoplasmic reticulum (ER) reticulon homology proteins in peroxisome biogenesis.

Authors:  Christine David; Johannes Koch; Silke Oeljeklaus; Alexandra Laernsack; Sophie Melchior; Sebastian Wiese; Andreas Schummer; Ralf Erdmann; Bettina Warscheid; Cécile Brocard
Journal:  Mol Cell Proteomics       Date:  2013-05-20       Impact factor: 5.911

Review 2.  Zebrafish as a model to investigate CNS myelination.

Authors:  Marnie A Preston; Wendy B Macklin
Journal:  Glia       Date:  2014-09-27       Impact factor: 7.452

3.  Rab27b is Involved in Lysosomal Exocytosis and Proteolipid Protein Trafficking in Oligodendrocytes.

Authors:  Yun-Tian Shen; Yun Gu; Wen-Feng Su; Jing-Fei Zhong; Zi-Han Jin; Xiao-Song Gu; Gang Chen
Journal:  Neurosci Bull       Date:  2016-06-21       Impact factor: 5.203

4.  A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination.

Authors:  Tuancheng Feng; Rory R Sheng; Santiago Solé-Domènech; Mohammed Ullah; Xiaolai Zhou; Christina S Mendoza; Laura Camila Martinez Enriquez; Isabel Iscol Katz; Daniel H Paushter; Peter M Sullivan; Xiaochun Wu; Frederick R Maxfield; Fenghua Hu
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

5.  Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model.

Authors:  Inderjit Singh; Devadoss J Samuvel; Seungho Choi; Nishant Saxena; Avtar K Singh; Jeseong Won
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

6.  Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets.

Authors:  Max Lam; Joey W Trampush; Jin Yu; Emma Knowles; Gail Davies; David C Liewald; John M Starr; Srdjan Djurovic; Ingrid Melle; Kjetil Sundet; Andrea Christoforou; Ivar Reinvang; Pamela DeRosse; Astri J Lundervold; Vidar M Steen; Thomas Espeseth; Katri Räikkönen; Elisabeth Widen; Aarno Palotie; Johan G Eriksson; Ina Giegling; Bettina Konte; Panos Roussos; Stella Giakoumaki; Katherine E Burdick; Antony Payton; William Ollier; Ornit Chiba-Falek; Deborah K Attix; Anna C Need; Elizabeth T Cirulli; Aristotle N Voineskos; Nikos C Stefanis; Dimitrios Avramopoulos; Alex Hatzimanolis; Dan E Arking; Nikolaos Smyrnis; Robert M Bilder; Nelson A Freimer; Tyrone D Cannon; Edythe London; Russell A Poldrack; Fred W Sabb; Eliza Congdon; Emily Drabant Conley; Matthew A Scult; Dwight Dickinson; Richard E Straub; Gary Donohoe; Derek Morris; Aiden Corvin; Michael Gill; Ahmad R Hariri; Daniel R Weinberger; Neil Pendleton; Panos Bitsios; Dan Rujescu; Jari Lahti; Stephanie Le Hellard; Matthew C Keller; Ole A Andreassen; Ian J Deary; David C Glahn; Anil K Malhotra; Todd Lencz
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.995

Review 7.  Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.

Authors:  Keigo Takahashi; Hemanth R Nelvagal; Jenny Lange; Jonathan D Cooper
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

8.  Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies.

Authors:  Xiaolai Zhou; Alexandra M Nicholson; Yingxue Ren; Mieu Brooks; Peizhou Jiang; Aamir Zuberi; Hung Nguyen Phuoc; Ralph B Perkerson; Billie Matchett; Tammee M Parsons; NiCole A Finch; Wenlang Lin; Wenhui Qiao; Monica Castanedes-Casey; Virginia Phillips; Ariston L Librero; Yan Asmann; Guojun Bu; Melissa E Murray; Cathleen Lutz; Dennis W Dickson; Rosa Rademakers
Journal:  Brain       Date:  2020-06-01       Impact factor: 15.255

9.  Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.

Authors:  Xiaolai Zhou; Mieu Brooks; Peizhou Jiang; Shunsuke Koga; Aamir R Zuberi; Matthew C Baker; Tammee M Parsons; Monica Castanedes-Casey; Virginia Phillips; Ariston L Librero; Aishe Kurti; John D Fryer; Guojun Bu; Cathleen Lutz; Dennis W Dickson; Rosa Rademakers
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

Review 10.  Developing therapeutic approaches for metachromatic leukodystrophy.

Authors:  Shilpa A Patil; Gustavo H B Maegawa
Journal:  Drug Des Devel Ther       Date:  2013-08-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.